FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Inhibitor topics
Atherosclerosis
Computer Program
Circulation
Fluidically
Hypertension
Nucleic Acid
Oxidative Stress
Pyrrolidine
Hepatitis C
Hepatitis C Virus
Methyl Ester
Crystallin
Antagonist
Immunogenic
Polypeptide

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Inhibitor patents



      
           
This page is updated frequently with new Inhibitor-related patent applications. Subscribe to the Inhibitor RSS feed to automatically get the update: related Inhibitor RSS feeds. RSS updates for this page: Inhibitor RSS RSS


Date/App# patent app List of recent Inhibitor-related patents
08/28/14
20140243536
 Serotonin reuptake inhibitors patent thumbnailnew patent Serotonin reuptake inhibitors
Where x, y, r1, r2, r3, r4, r4, and n are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula i are serotonin reuptake inhibitors.
08/28/14
20140243521
 Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates patent thumbnailnew patent Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates
A synthesis approach providing an early ring attachment via a bromination to compound 1-1 yielding compound ii-i1, whereby a final product such as aa can be synthesized. In particular, the 2,4-difluorophenyl-containing sidechain is attached before creation of the additional ring q..
08/28/14
20140243520
 Pyrrolopyridines as kinase inhibitors patent thumbnailnew patent Pyrrolopyridines as kinase inhibitors
Compounds of formula i are useful for inhibition of chk1 and/or chk2. Methods of using compounds of formula i and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed..
08/28/14
20140243519
 Methods and intermediates for preparing macrolactams patent thumbnailnew patent Methods and intermediates for preparing macrolactams
The present invention includes compounds useful as intermediates in the preparation of macrolactams, methods for preparing the intermediates, and methods for preparing macrolactams. One use of the methods and intermediates described herein is in the production of macrolactam compounds able to inhibit hcv ns3 protease activity.
08/28/14
20140243517
 Methods of producing c-aryl glucoside sglt2 inhibitors patent thumbnailnew patent Methods of producing c-aryl glucoside sglt2 inhibitors
Method for the production of c-aryl glucoside sglt2 inhibitors useful for the treatment of diabetes and related diseases. And intermediates thereof.
08/28/14
20140243501
 Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments patent thumbnailnew patent Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments
The invention provides histone deacetylase (hdac) inhibitors shown as formula i, where r1 to r8 are as defined in the specification. The invention also provides methods for synthesis of these compounds and applications of these compounds in preparing pharmaceuticals for preventing or treating mammal diseases related to the dysregulation of hdac..
08/28/14
20140243416
 Topical antiandrogen therapy for the treatment of becker's nevus patent thumbnailnew patent Topical antiandrogen therapy for the treatment of becker's nevus
This invention relates to the treatment of beckers nevus with antiandrogenic topical agents, including 5-alpha reductase inhibitors, non-steroidal antiandrongens and steroidal antiandrogens.. .
08/28/14
20140243414
 Pharmaceutical compositions of cetp inhibitors patent thumbnailnew patent Pharmaceutical compositions of cetp inhibitors
The invention provides pharmaceutical compositions comprising a cholesteryl ester transfer protein (cetp) inhibitor and a water-insoluble concentration-enhancing additive, which exhibit improved bioavailability. The invention also provides methods of treating cardiovascular disorders comprising the administration of the pharmaceutical compositions comprising a cetp inhibitor..
08/28/14
20140243401
 Methods of screening compounds that are cytotoxic to tumor cells and methods of treating tumor cells using such compound patent thumbnailnew patent Methods of screening compounds that are cytotoxic to tumor cells and methods of treating tumor cells using such compound
The invention relates to methods of screening to find compounds that are cytotoxic to tumor cells and methods of treating tumor cells using these compounds. In particular, the invention relates to methods of screening for compounds that inhibit mammalian mitochondrial fatty acid synthase (mmfas) and methods of treating tumor cells using mmfas inhibitors.
08/28/14
20140243382
 Inhibitors of c-fms kinase patent thumbnailnew patent Inhibitors of c-fms kinase
Wherein z, x, j, r2 and w are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of formula i, are also provided..
08/28/14
20140243380
new patent Combination therapy with nitrated lipids and inhibitors of the renin-angiotensin-aldosterone system
The present technology provides compositions and methods for treating chronic kidney disease, end-stage renal disease, or diabetic nephropathy. The compositions comprise a nitrated lipid and an inhibitor of the renin-angiotensin-aldosterone system.
08/28/14
20140243374
new patent Novel sulfonamides
This invention relates generally to the discovery of sulfonamide-containing compounds that are inhibitors of γ-secretase.. .
08/28/14
20140243372
new patent Benzoic acid derivative mdm2 inhibitor for the treatment of cancer
The present invention provides a mdm2 inhibitor compound, or a pharmaceutically acceptable salt thereof, which compound is useful as a therapeutic agent, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contains the mdm2 inhibitor..
08/28/14
20140243370
new patent Pyrano[3,2-d][1,3]thiazole as glycosidase inhibitors
Wherein r1 to r4 and x have the meaning according to the claims, are glucosidase inhibitors, and can be employed, inter alia, for the treatment of alzheimer's disease.. .
08/28/14
20140243369
new patent Synthesis of a glycosyltransferase inhibitor
Process for the preparation of animinosugar, and the intermediates thereof, having known activity as a glycosyltransferase inhibitor and used, for example, in the treatment of gaucher's disease.. .
08/28/14
20140243361
new patent Polymorphs of arry-380, a selective herb2 inhibitor and pharmaceutical compositions contianing them
Polymorphs of n4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-n6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed..
08/28/14
20140243360
new patent Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase inhibitors
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of janus kinases and are useful in the treatment of diseases related to activity of janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.. .
08/28/14
20140243355
new patent Inhibitors of bruton's tyrosine kinase
Disclosed herein are compounds that form covalent bonds with bruton's tyrosine kinase (btk). Also described are irreversible inhibitors of btk.
08/28/14
20140243353
new patent 5- or 6-substituted 3-hydroxy-2(1h)-pyridinones as d-amino acid oxidase (daao) inhibitors in therapy of diseases such as schizophrenia, cognitive disorder and paid
The present invention provides compounds of formula (i) and pharmaceutically acceptable salts thereof, wherein r1 is hydrogen or fluorine, one of a and b is r2, the other is a group —x—y—r3. R3 represents a carbocyclic or heterocyclic ring.
08/28/14
20140243347
new patent Substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2h)-one derivatives as kinases inhibitors
The present invention relates to substituted 3,4-dihydropyrrolo[1,2-a]pyrazin-1(2h)-one derivatives which modulate the activity of protein kinases and are therefore useful in treating diseases caused by dysregulated protein kinase activity. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing such compounds or the pharmaceutical compositions containing them..
08/28/14
20140243345
new patent Selective hdac3 inhibitors
Provided herein are hdac3 inhibitors, as well as methods of treatment comprising administering these compounds to a subject in need thereof.. .
08/28/14
20140243341
new patent Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
Antiviral protease inhibitors, including peptidyl aldehydes, peptidyl α-ketoamides, peptidyl bisulfite salts, and peptidyl heterocycles, are disclosed, along with related antiviral compounds, and methods of using the same to treat or prevent viral infection and disease. The compounds possess broad-spectrum activity against viruses that belong to the picornavirus-like supercluster, which include important human and animal pathogens including noroviruses, enteroviruses, poliovirus, foot-and-mouth disease virus, hepatitis a virus, human rhinovirus (cause of common cold), human coronavirus (another cause of common cold), transmissible gastroenteritis virus, murine hepatitis virus, feline infectious peritonitis virus, and severe acute respiratory syndrome coronavirus..
08/28/14
20140243340
new patent Cytochrome p450 oxidase inhibitors and uses thereof
Or pharmaceutically acceptable salts, solvates or prodrugs thereof, and methods of using the same to inhibit the metabolizing activities of cyp enzymes. The present invention also features methods of using these compounds, salts, solvates or prodrugs to improve the pharmacokinetics of drugs that are metabolized by cyp enzymes..
08/28/14
20140243339
new patent Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer
This invention is in the field of pharmaceutical agents and specifically relates to compounds, compositions, uses and methods for treating cancer, by combining vegf(r) inhibitors and inhibitors of hgf/sf:c-met.. .
08/28/14
20140243338
new patent Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors
Or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective rock inhibitors.
08/28/14
20140243337
new patent Phenyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
The invention provides certain phenyl carboxamide-containing compounds of the formula (i); or pharmaceutically acceptable salts thereof, wherein a and b are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by spleen tyrosine kinase (syk) kinase..
08/28/14
20140243336
new patent 2-pyridyl carboxamide-containing spleen tyrosine kinase (syk) inhibitors
The invention provides certain 2-pyridyl carboxamide-containing compounds of the formula (i) or pharmaceutically acceptable salts thereof, wherein a and b are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by spleen tyrosine kinase (syk) kinase..
08/28/14
20140243335
new patent Substituted hydoxamic acids and uses thereof
Wherein r1, r1b, r2a, r2b, r2c, and r2d have values as described in the specification, useful as inhibitors of hdac6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders..
08/28/14
20140243334
new patent Substituted hydoxamic acids and uses thereof
Wherein r1a, r1b, r1c, r2a, r2b, r2c, and r2d have values as described in the specification, useful as inhibitors of hdac6. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders..
08/28/14
20140243331
new patent Inhibitors of inv(16) leukemia
This invention describes the development of targeted small molecule inhibitors of the inv(16) fusion, the causative agent in ˜12% of acute myeloid leukemia (aml). The inv(16) fusion results in expression of the cbfβ-smmhc fusion protein in the blood cells of afflicted patients.
08/28/14
20140243330
new patent Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
Pharmaceutical compositions comprising such compounds and the use of such compounds in the treatment of phosphoinositide 3-kinase related diseases and disorders such as cancer. The instant application further relates to the treatment of histone deacetylase related disorders and diseases related to both histone deacetylase and phosphoinositide 3-kinase..
08/28/14
20140243325
new patent 1,3-oxazines as bace1 and/or bace2 inhibitors
Having bace1 and/or bace2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g.
08/28/14
20140243320
new patent Novel compound having parp inhibitory activity
A compound represented by the following general formula (1) or a salt thereof. R1 represents a halogen atom and so on; r2 and r3 each represent a hydrogen atom and so on; r4 and r5 each represent a hydrogen atom and so on, or r4 and r5 may form an oxo group; ra and rb each represent a lower alkyl group optionally having a substituent and so on, or they may bind to each other to form a nitrogen-containing heterocyclic ring which may be substituted by one or plural rc; rc represents an aryl group optionally having a substituent and so on; ring a represents a benzene ring and so on; and m represents 0, 1 or 2..
08/28/14
20140243315
new patent Pyrrolopyrimidine compounds for the treatment of cancer
The ectopic expression of mer receptor tyrosine kinase (mer) has been identified as a tumor cell survival gene product in acute lymphoblastic leukemia (all) cells and a potential cause of all chemoresistance. Hence, we investigated whether the development of small molecule mer inhibitors was possible.
08/28/14
20140243314
new patent Quinolinone carboxamide inhibitors of endothelial lipase
The present invention provides compounds of formula (i): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments..
08/28/14
20140243312
new patent Pyrrolo[2,3-d]pyrimidine derivatives
Described herein are pyrrolo{2,3-d}pyrimidine derivatives, their use as janus kinase (jak) inhibitors, and pharmaceutical compositions containing them.. .
08/28/14
20140243309
new patent Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors
The instant invention provides compounds of formula i which are jak inhibitors, and as such are useful for the treatment of jak-mediated diseases such as rheumatoid arthritis, asthma, copd and cancer.. .
08/28/14
20140243308
new patent Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
The present invention relates to substituted imidazopyridazines and substituted benzimidazoles, as well as pharmaceutical compositions comprising the same, which are fgfr3 inhibitors useful in the treatment of cancer and other diseases.. .
08/28/14
20140243305
new patent Azetidinyl diamides as monoacylglycerol lipase inhibitors
Wherein y, z, r1, and s are defined herein.. .
08/28/14
20140243303
new patent Spirocyclic molecules as protein kinase inhibitors
R2 is selected from. .
08/28/14
20140243292
new patent Subsituted 2-(chroman-6-yloxyl)-thiazoles and their use as pharmaceuticals
In which ar, r2, r3 and r4 are as defined in the claims. The compounds of the formula i are inhibitors of the sodium-calcium exchanger (ncx), especially of the sodium-calcium exchanger of subtype 1 (ncx1), and are suitable for the treatment of diverse disorders in which intracellular calcium homeostasis is disturbed, such as arrhythmias, heart failure and stroke.
08/28/14
20140243290
new patent Aminopyrimidines as syk inhibitors
The present invention provides novel pyrimidine amines of formula (i) which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, copd and rheumatoid arthritis.. .
08/28/14
20140243281
new patent Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
Provided herein are pediatric dosage forms for use in the treatment of a pediatric cholestatic liver disease by non-systemically administering to an individual in need thereof a therapeutically effective amount of the pediatric dosage form comprising an apical sodium-dependent bile acid transporter inhibitor (asbti) or a pharmaceutically acceptable salt thereof. Also provided are said pediatric dosage form for use in the treatment of a pediatric liver disease, for use in decreasing the levels of serum bile acids or hepatic bile acids, for use in the treatment of pruritis, for use in reducing liver enzymes or bilirubin comprising non-systemically administering to an individual in need thereof a therapeutically effective amount of a pediatric formulation comprising an asbti or a pharmaceutically acceptable salt thereof..
08/28/14
20140243275
new patent Galectin-3c combination therapy for human cancer
The present invention provides a novel composition of matter useful for the treatment of neoplastic diseases. The novel composition is synergistic and comprised of galectin-3c in combination with a proteosome inhibitor, the combination having a pharmacologic activity greater than the expected additive effect of its individual components.
08/28/14
20140243262
new patent Pharmaceutical formulations containing an sglt2 inhibitor
And a pharmaceutical acceptable carrier therefor, which formulation is designed for immediate release.. .
08/28/14
20140243239
new patent Multiplexed kinase inhibitor beads and uses thereof
This invention is directed to a multi-analyte column comprising two or more layers with a first solid support having specific binding affinity for kinases and a second solid support having non-specific binding affinity for kinases. Methods are also provided, including methods of detecting low abundance kinases, predicting resistance to chemotherapy, determining cancer prognosis, and improving the effectiveness of a treatment regimen..
08/28/14
20140243225
new patent Multiplex compositions and methods for quantification of human nuclear dna and human male dna and detection of pcr inhibitors
The invention relates to a method for simultaneous quantification of human nuclear dna and human male dna in a biological sample while also detecting the presence of pcr inhibitors in a single reaction. The multiplex quantification method also provides a ratio of human nuclear and male dna present in a biological sample.
08/28/14
20140243198
new patent Methods of weed control in pineapple
Disclosed herein are methods of controlling undesirable vegetation in pineapple, which comprise applying to vegetation or an area adjacent the vegetation or applying to soil to prevent the emergence or growth of vegetation (a) penoxsulam or an agriculturally acceptable salt thereof. The methods can further comprise applying (b) a second pesticide or an agriculturally acceptable salt or ester thereof to the vegetation or the area adjacent the vegetation or to the soil adjacent thereto.
08/28/14
20140242702
new patent Methods and compositions for enhancing nuclease-mediated gene disruption
Methods and compositions for increasing nuclease-mediated genomic modification using dna repair inhibitors are provided.. .
08/28/14
20140242621
new patent Method for determining protein s activity
The invention relates to a method for determining the protein ca-cofactor activity of protein s, wherein the protein ca-cofactor activity of protein s is measured in a first reaction volume in the absence of a protein s inhibitor and in a second reaction volume in the presence of a protein s inhibitor. The protein ca-cofactor activity of protein s is determined by calculating the quotient of the assay result of the first reaction volume and the assay result of the second reaction volume..
08/28/14
20140242609
new patent Diagnosis and treatment of kidney stones, methods and compositions therefor
Methods of detecting, diagnosing, monitoring and treating kidney stones are disclosed. In some embodiments, methods of detecting, diagnosing or monitoring kidney stones comprise contacting a urine sample with anti-claudin-14 antibody, and detecting quantity of a complex comprising claudin-14 and the antibody, wherein an increase compared to control levels is diagnostic for kidney stones.
08/28/14
20140242602
new patent Uses of labeled hsp90 inhibitors
The disclosure provides evidence that the abundance of this particular “oncogenic hsp90” species, which is not dictated by hsp90 expression alone, predicts for sensitivity to hsp90 inhibition therapy, and thus is a biomarker for hsp90 therapy. The disclosure also provides evidence that identifying and measuring the abundance of this oncogenic hsp90 species in tumors predicts of response to hsp90 therapy.
08/28/14
20140242597
new patent Predicting tumor response to anti-erbb3 antibodies
A diagnostic method for predicting quantitatively whether a human tumor will be sensitive or resistant to treatment with an erbb3 inhibitor, e.g, an anti-erbb3 antibody, is disclosed. The method is based on measurement of nrg1 expression at the rna level, or at the protein level, in a tissue sample from the tumor..
08/28/14
20140242584
new patent Genomic dna extraction reagent and method
The present invention is directed to a genomic dna extraction reagent and method for improved extraction of dna from biological tissue. The extraction reagent of the invention is mixed with disrupted biological tissue to form a dna extraction solute which is incubated in a dna extraction step.
08/28/14
20140242580
new patent Method for predicting response or prognosis of lung adenocarcinoma with egfr-activating mutations
The invention provides a method for predicting the response of an egfr-activating mutant subject suffering from a lung adenocarcinoma and receiving treatment with epidermal growth factor receptor tyrosine kinase inhibitor (egfr-tki) and a method for predicting prognosis in an egfr-activating mutant subject suffering from a lung adenocarcinoma and receiving treatment with egfr-tki. In the methods of the invention, clustered genomic alterations in specific chromosomes (in particular chromosomes 5p, 7p, 8q or 14q) are determined as a tool for predicting the response or prognosis..
08/28/14
20140242299
new patent Corrosion inhibitor injecting method
A method for injecting a corrosion inhibitor injecting an oxidant and an anticorrosive agent-ph adjusting agent complex including an anticorrosive agent and a ph adjusting agent adsorbed on a surface of the anticorrosive agent into high temperature water in contact with a surface of a metal structural material and irradiating the high temperature water with a radioactive ray or an ultraviolet ray, wherein the anticorrosive agent of the anticorrosive agent-ph adjusting agent complex has, on the surface of the anticorrosive agent, an active site where the ph adjusting agent reacts with the oxidant, and the ph adjusting agent present on the surface of the anticorrosive agent of the anticorrosive agent-ph adjusting agent complex and/or in the high temperature water is oxidized with the oxidant by the irradiation with the radioactive ray or the ultraviolet ray to change ph adjusting ability of the ph adjusting agent and shift a ph of the high temperature water to a neutral side, and thereby deposition of the anticorrosive agent 11 to the metal structural material 65 is accelerated.. .
08/28/14
20140242153
new patent Novel encochleation methods, cochleates and methods of use
Disclosed are novel methods for making cochleates and cochleate compositions that include introducing a cargo moiety to a liposome in the presence of a solvent. Also disclosed are cochleates and cochleate compositions that include an aggregation inhibitor, and optionally, a cargo moiety.
08/28/14
20140242096
new patent Compositions and methods related to graft versus host disease and treatments thereof
Embodiments of the present invention illustrate methods of treating and preventing transplantation and side effects associated with transplantation. In particular, the present invention relates to compositions and methods for inhibition of graft rejection and promotion of graft survival.
08/28/14
20140242091
new patent Method for treating pathologies associated with hypoxia using mif inhibitors
Methods are provided for treating pathologies associated with hypoxia with an mif inhibitor. Methods are also provided for treating a subject having, or at risk for pulmonary hypertension, with an mif inhibitor.
08/28/14
20140242089
new patent Glycoproteins having lipid mobilising properties and therapeutic applications thereof
A biologically active lipid mobilising agent for use in therapy is disclosed which has the properties and characteristics of a zn-α2-glycoprotein, or of a fragment thereof having an apparent molecular mass mr greater than 6.0 kda as determined by gel exclusion chromatography. Methods of isolation and purification from biological material are also disclosed together with uses of the material for making up pharmaceutical compositions, especially pharmaceutical compositions useful for treating mammals to achieve weight reduction or for controlling obesity.
08/28/14
20140242088
new patent Hsp90 inhibitor combinations
A pharmaceutical combination comprising an hsp90 inhibitor and an mtor inhibitor, and methods of using the combination to treat or prevent proliferative disorders.. .
08/28/14
20140242078
new patent Methods and monitoring of treatment with a wnt pathway inhibitor
Methods for treating diseases such as cancer comprising administering a wnt pathway inhibitor, either alone or in combination with other anti-cancer agents, and monitoring for skeletal-related side effects and/or toxicity.. .
08/28/14
20140242069
new patent Krt19 stabilizing her2 and use thereof
Provided is a method of decreasing the stability of her2 (human epidermal growth factor receptor 2) in a cell or individual comprising administering an effective amount of an expression or activity inhibitor of krt19 (cytokeratin 19) to the cell or individual.. .
08/28/14
20140242029
new patent Combination therapy for treating hcv infection in an hcv-hiv coinfected patient population
The present invention relates to therapeutic combinations comprising (a) compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the hcv ns3 serine protease.
08/28/14
20140242027
new patent Substituted pyridine and pyrimidine derivatives and their use in treating viral infections
The present invention provides compounds of formula (i): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of r, r1, x, y, z, r2, r3, r4, r5, r6, r7, r8, r9, r18, r19 and n is selected independently and as defined herein. Compositions comprising such compounds are also provided.


Popular terms: [SEARCH]

Inhibitor topics: Atherosclerosis, Computer Program, Circulation, Fluidically, Hypertension, Nucleic Acid, Oxidative Stress, Pyrrolidine, Hepatitis C, Hepatitis C Virus, Methyl Ester, Crystallin, Antagonist, Immunogenic, Polypeptide

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Inhibitor for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Inhibitor with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.3077

3915

1 - 1 - 83